Novo Nordisk Recalls TRESIBA Insulin Samples Due to Temperature Abuse
Novo Nordisk is recalling TRESIBA (insulin degludec) samples stored below 32°F, which may cause lack of efficacy and damage to the cartridge and pen-injectors.
- Product
- TRESIBA — TRESIBA (INSULIN DEGLUDEC)
- Category
- Drug
- Distribution
- Distributed nationwide